Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Aug 1, 2011 → Sep 1, 2012

About Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo

Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo is a phase 1 stage product being developed by Sun Pharmaceutical for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01513863. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01513863Phase 1Completed